Home Blog Page 226

Kroger finishes Roundy’s acquisition

0
Kroger finishes Roundy's acquisition

The Kroger Co. has recently completed its acquisition of Roundy’s Inc. The completed acquisition means that Kroger is now the grocery market share leader in metro Milwaukee.

“This merger blends Roundy’s complementary markets with Kroger’s strengths in scale and merchandising,” said Rodney McMullen, Kroger’s chairman and CEO, in a release. At the moment, Roundy’s Pick ‘n Save has roughly 39 per cent of the Milwaukee market. Additionally, the recent acquisition gives Kroger Roundy’s 32 per cent share of the grocery market in the state of Wisconsin.

Kroger, considered one of the world’s largest retailers, has more than 422,000 employees in 2,774 supermarkets and multi-department stores in 35 states and the District of Columbia.

Sobeys Express opens shop in Nova Scotia

0
Sobeys Express opens shop in Nova Scotia

Sobeys has combined a gas bar and a grocery outlet together—using a convenience store format. Recently, the grocery retailer opened such a store, known as Sobeys Express, in Nova Scotia. This new grocery shopping hybrid combines traditional grocery store products with healthier, and quicker, meals and snacks to a Shell-branded gas station.

“Consumer research has shown us that customers are looking for more fresh food options to meet their on-the-go needs. They also want a one-stop shop for food and fuel and Sobeys express meets those customer needs in a larger and brighter store,” remarked Valerie Ryan, vice president, convenience and fuel, Sobeys Atlantic.

Sobeys opened a similar store in Quebec two years ago. The grocery retailer plans to open more Sobeys Express stores, combined with Shell’s-branded gas, across the Atlantic Canada.

Pioneering Neuroprotective Results Achieved in Parkinson’s Disease Preclinical Studies

0

According to a team of scientists at the University of Nebraska Medical Center (UNMC) and Longevity Biotech, Inc., neuroprotection could be attained in preclinical models by a novel drug candidate that changes immune responses.  The results, published on December 16 in the Journal of Neuroscience, describe the prevention of nerve cell damage in a mouse model of Parkinson’s disease.  Notably, the drug protected nerve cells that produce dopamine, which is the chemical responsible for agility and movement that is lost in human disease.

 

“The idea was birthed nearly a decade ago when specific types of circulating blood cells called lymphocytes were found to damage the types of nerve cells responsible for disease,” says Howard Gendelman, M.D., the Margaret R. Larson Professor and chair of the UNMC Department of Pharmacology and Experimental Neuroscience.  “The new Longevity Biotech drug (LBT-3627) was able to change the function of these cells from killing the nerve cells to protecting them. This is especially significant for the Nebraska team, as the mechanism parallels closely the human trials nearing completion for Parkinson’s patients.”

 

According to Longevity Biotech, LBT-3627 is similar to the naturally occurring vasoactive intestinal peptide (VIP), a well-established anti-inflammatory peptide. It is rapidly degraded by the body and is unable to distinguish between its two naturally intended receptors (VPAC1 vs. VPAC2). These limitations have stymied prior translational success using VIP.

 

In contrast, LBT-3627 specifically targets VPAC2 and demonstrates impressive biological durability. Scott Shandler, Ph.D., co-founder and CEO of Longevity Biotech, says LBT-3627 has the potential to be administered orally, which would further improve its clinical prospects and make it more accessible for people with Parkinson’s disease.

 

Preclinical studies performed by the UNMC team demonstrated that LBT-3627 could achieve up to 80 per cent protection of dopamine-producing nerve cells in a mouse model of Parkinson’s disease.  Furthermore, the immune transformation also affected primary scavenger cells, called microglia cells, that were found ultimately responsible for the neuroprotective activities observed that halted brain damage.

Canadian consumers enjoy music while they shop

0
Canadian consumers enjoy music while they shop

A new survey from the Society of Composers, Authors and Music Publishers of Canada (SOCAN) and polling firm Leger suggests that 58 per cent of Canadians find that music makes shopping in the supermarket more enjoyable.

Additionally, 28 per cent of consumers feel music slows their shopping, while 24 per cent believe music causes them to stay in the supermarket longer. Moreover, 33 per cent admitted to singing and dancing in the aisles, while another 33 per cent said they’ve lingered in a store to finish hearing a song they’ve especially enjoyed.

“Every minute you stay a store is another product you buy,” says Leslie Craig, director of licensing operations for SOCAN. Craig adds that more Canadians enjoy hearing music in grocery stores than she had assumed prior to doing the survey.

“You’d expect those kinds of numbers in restaurants and other types of retailers, but maybe not in a grocery store, which people shop so often,” she says.

However, not everyone enjoys rocking out in the supermarket—19 per cent of those surveyed do not want to hear any music.

Older shoppers are among those who prefer the sound of silence: 42 per cent of those 65 and up said they don’t like to hear music in a grocery store, followed by 22 per cent among the 55-to-64 set.

Fiddleheads Health and Nutrition launches Smoothie Bar Café

0
Fiddleheads Health and Nutrition launches Smoothie Bar Café

Fiddleheads Health and Nutrition has launched Fiddleheads Smoothie Bar Café, located across from Wilfrid Laurier University in Waterloo. The company, which was launched in 1999, has been providing to provide natural health products out of its retail locations for the past 16 years.

Kim Boril, founder of Fiddleheads, notes that the smoothies sold in Fiddleheads’ Cambridge store were a popular attraction. As such, she decided to create a higher-level destination for whole, local food options and nutritious smoothies.

“I think people are ready for the healthy, faster food type of thing now,” said Boril. “I don’t think this concept would have worked as well five years ago, but I think enough people are used to smoothies that they understand it.”

The Café currently produces 20 different smoothies and offers certain add-ins like fibre and immune boosters.

“Our smoothies are different than other smoothies in that we’ve really looked at lowering the sugar content,” said Boril. “They taste delicious but they still have the health properties we promote, and they have tons of good stuff in them, including greens and proteins.”

For more information, visit fiddleheadshealth.com.

Hemp growers pressure Canadian Government to recognize health claim

0
Hemp growers pressure Canadian Government to recognize health claim

Canadian hemp growers are pushing Health Canada to recognize their plant as a beneficial natural health product. At the annual meeting of the Canadian Hemp Trade Alliance, members voted to push for a health claim on food products.

Like marijuana, hemp is part of the cannabis plant family, and is grown for industrial purposes such as food, fibre and fuel.

Canada’s hemp oil products contain less than 10 parts per million of tetrahydrocannabinol (THC), the ingredient’s psychoactive component. Additionally, it carries high levels of omega fatty acids and other chemicals, some of which are showing potential as antidepressants.

“Canadian farmers are suffering because they are missing out on a traditional revenue stream that other farmers in other jurisdictions are gaining,” says Sara Zborovski, a lawyer who works with companies seeking approval from Health Canada for food products. As such, a health claim rating could be extremely profitable for hemp farmers.

Zborovski adds that it would have to be made clear that hemp products are not the same as medical marijuana. Instead, the claim must focus on hemp oil and other byproducts.

Work on a proposal for Health Canada could start by February.

Choices Markets to open North Vancouver store

0
Choices Markets to open North Vancouver store

Vancouver-based grocer Choices Market has announced plans to open its 11th location this spring. The new 12,000-square-foot North Vancouver store will be located in Capilano Village at 801 Marine Drive.

“North Vancouver is a hub for active health-conscious, community-minded citizens, and the population is definitely growing,” says Choices CEO Ishkandar Ahmed about his decision to open in the area.

This announcement follows The 25-year-old company’s 2015 openings of stores on Commercial Drive in Vancouver, as well as in Burnaby and Abbotsford.

CVS Health acquires Target’s pharmacy and clinic businesses

0
CVS Health acquires Target’s pharmacy and clinic businesses

CVS Health Corporation has announced its acquisition of Target Corporation’s pharmacy and clinic businesses for $1.9 billion. With this, CVS Health acquired 1,672 of Target’s pharmacies across 47 states, and will operate them through a store-within-a-store format, branded as CVS/pharmacy.

Additionally, a CVS/pharmacy will be included in all new Target stores that offer pharmacy services, and seventy-nine Target clinic locations will be rebranded as MinuteClinic. CVS Health will also open up to 20 new clinics in Target stores within the next three years.

“Today’s milestone in our relationship with CVS Health is an important step in driving Target’s strategic priorities forward while giving our guests easy access to industry-leading health care services,” says Brian Cornell, chairman and CEO of Target. “With the transition now underway, Target can further accelerate our commitment to wellness as a signature category, helping guests and team members in their efforts to eat better, be more active and find natural and clean label products.”

The Target pharmacies and clinics will be placed under the CVS Health banners and systems within six to eight months.

Valeant announces new U.S. fulfillment agreement with Walgreens

0

Valeant Pharmaceuticals International, Inc. has announced new fulfillment agreements with Walgreens. In conjunction with this deal, Valeant will reduce the wholesale list prices of its branded prescription-based dermatological and ophthalmological products by 10 per cent over the next six to nine months.

This model is designed to help reduce costs and administrative processes, yielding savings that can benefit both patients and the healthcare system. The agreement will enable consumers to conveniently access Valeant’s products at a lower out-of-pocket cost from more than 8,000 Walgreens U.S. retail pharmacy locations, as well as participating independent retailers.

Through this, the company aims to create a more efficient model to help lower costs while ensuring patients have convenient access to the products their doctors prescribe. Patients with commercial insurance can benefit from lower out-of-pocket costs, such as reduced copays, and the program will provide convenient access for patients who lack coverage for the products. (Zolpidem) However, due to government regulation, the cost-sharing program will not be applicable to patients with government insurance.

“We have listened to what the marketplace is saying and we’ve taken positive steps to respond,” says J. Michael Pearson, chairman and CEO of Valeant. “Our goal is to create a system that allows prescription medications to be dispensed and insurance claims adjudicated in an efficient manner while allowing physicians to focus their efforts on what matters most: patient care.”

Stress in Elderly People Increases Risk for Pre-Alzheimer’s Condition

0

According to a study “Influence of perceived stress on incident amnestic mild cognitive impairment: Results from the Einstein Aging Study” from Albert Einstein College of Medicine and Montefiore Health System, highly stressed elderly people are more than twice as likely to develop mild cognitive impairment–often a prelude to Alzheimer’s disease–than those who are not stressed. This study looked at the connection between chronic stress and “amnestic mild cognitive impairment (aMCI), the most common type of MCI, which is primarily characterized by memory loss. The findings were published online in Alzheimer Disease & Associated Disorders.

 

“Our study provides strong evidence that perceived stress increases the likelihood that an older person will develop aMCI,” said Richard Lipton, MD, senior author of the study, vice chair of neurology at Einstein and Montefiore, and professor in the Saul R. Korey Department of Neurology and the Edwin S. Lowe Chair of Neurology at Einstein. “Fortunately, perceived stress is a modifiable risk factor for cognitive impairment, making it a potential target for treatment.”

 

The study’s first author Mindy Katz, M.P.H., senior associate in the Saul R. Korey Department of Neurology at Einstein says that “perceived stress can be altered by mindfulness-based stress reduction, cognitive-behavioral therapies and stress-reducing drugs. These interventions may postpone or even prevent an individual’s cognitive decline.”

 

The researchers studied data collected from 507 people enrolled in the Einstein Aging Study (EAS), a community-based cohort of older adults. Starting in 2005, the EAS began assessing stress using the Perceived Stress Scale (PSS). This widely used 14-item measure of psychological stress was designed to be sensitive to chronic stress (due to ongoing life circumstances, possible future events and other causes) perceived over the previous month. PSS scores range from 0 to 56, with higher scores indicating greater perceived stress.

 

The diagnosis of aMCI was based on standardized clinical criteria including the results of recall tests and reports of forgetfulness from the participants or from others. All 507 enrollees were free of aMCI or dementia at their initial PSS assessment and subsequently underwent at least one annual follow-up evaluation. They were followed for an average of 3.6 years.

 

Seventy-one of the 507 participants were diagnosed with aMCI during the study. The greater the participants’ stress level, the greater their risk for developing aMCI: for every 5 point increase in their PSS scores, their risk of developing aMCI increased by 30 percent. Similar results were obtained when participants were divided into five groups (quintiles) based on their PSS scores. Participants in the highest-stress quintile (high stress) were nearly 2.5 times more likely to develop aMCI than were people in the remaining four quintiles combined (low stress).

 

This study suggests that detecting and treating stress in elderly people might help delay or even prevent the onset of Alzheimer’s.